Cash flow Zhejiang Medicine Co., Ltd.

Equities

600216

CNE0000010J2

Pharmaceuticals

End-of-day quote Shanghai S.E. Other stock markets 13/05/2026			5-day change	1st Jan Change
14.18 ^CNY	-1.32%		-1.05%	+2.31%

04-23	Zhejiang Medicine Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2026	CI
04-13	Zhejiang Medicine 2025 Profit Declines 25%; Shares Down 3%	MT

72a9d170b1d3.ayIocvPPXFz0POjyN9fPb5cI1S2yB4Qgvw2hCkAvTWw.PHRDRrW-KWzNet6ID72GX65c7ETlddZQzjTRWnhfBTMpWxsVguI_NZl5oQ

Published financial data: ZHEJIANG MEDICINE CO., LTD.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2021	2022	2023	2024	2025
Revenues	9.09B	8.07B	7.76B	9.34B	8.83B
Other Revenues, Total	41.3M	43.23M	32.11M	38.76M	46.23M
Total Revenues	9.13B	8.12B	7.79B	9.38B	8.88B
Cost of Goods Sold, Total	5.53B	5.44B	5.39B	5.59B	5.98B
Gross Profit	3.6B	2.68B	2.4B	3.78B	2.9B
Selling General & Admin Expenses, Total	1.55B	1.31B	1.48B	1.68B	1.41B
Provision for Bad Debts	10.63M	-2.94M	149K	12.55M	-3.67M
R&D Expenses	807M	809M	860M	749M	580M
Other Operating Expenses	73.84M	69.86M	78.43M	53.85M	51.37M
Other Operating Expenses, Total	2.44B	2.19B	2.42B	2.49B	2.04B
Operating Income	1.16B	490M	-18.15M	1.29B	860M
Interest Expense, Total	-39.54M	-33.11M	-28.34M	-26.37M	-24.82M
Interest And Investment Income	57.42M	13.18M	16.51M	22.51M	32.72M
Net Interest Expenses	17.89M	-19.94M	-11.82M	-3.86M	7.9M
Currency Exchange Gains (Loss)	-64.31M	66.6M	36.59M	17.82M	74.97M
Other Non Operating Income (Expenses)	-2.69M	-36.05M	21.09M	3.9M	-5.2M
EBT, Excl. Unusual Items	1.11B	500M	27.7M	1.31B	937M
Impairment of Goodwill	-	-8.12M	-9.23M	-18.68M	-
Gain (Loss) On Sale Of Investments	51.73M	-56.51M	-28.59M	-29.6M	4.64M
Gain (Loss) On Sale Of Assets	-7.95M	-2.04M	324M	-5.21M	-6.56M
Asset Writedown	-46.19M	-	-	-69.41M	-25.62M
Other Unusual Items	43.43M	57.71M	49.82M	26.77M	42.07M
EBT, Incl. Unusual Items	1.15B	491M	363M	1.21B	952M
Income Tax Expense	269M	129M	86.48M	192M	191M
Earnings From Continuing Operations	885M	363M	277M	1.02B	760M
Net Income to Company	885M	363M	277M	1.02B	760M
Minority Interest	161M	177M	153M	140M	113M
Net Income - (IS)	1.05B	540M	430M	1.16B	873M
Net Income to Common Incl Extra Items	1.05B	540M	430M	1.16B	873M
Net Income to Common Excl. Extra Items	1.05B	540M	430M	1.16B	873M
Per Share Items
Net EPS - Basic	1.09	0.56	0.45	1.21	0.91
Basic EPS - Continuing Operations	1.09	0.56	0.45	1.21	0.91
Basic Weighted Average Shares Outstanding	958M	958M	961M	962M	955M
Net EPS - Diluted	1.09	0.56	0.45	1.21	0.91
Diluted EPS - Continuing Operations	1.09	0.56	0.45	1.21	0.91
Diluted Weighted Average Shares Outstanding	958M	959M	961M	962M	955M
Normalized Basic EPS	0.89	0.51	0.18	1	0.73
Normalized Diluted EPS	0.89	0.51	0.18	1	0.73
Dividend Per Share	0.33	0.17	0.15	0.37	0.28
Payout Ratio	24.88	65.07	44.67	14.68	43.13
Supplemental Items
EBITDA	1.69B	1.11B	640M	1.95B	1.57B
EBITA	1.17B	504M	-2.82M	1.31B	876M
EBIT	1.16B	490M	-18.15M	1.29B	860M
EBITDAR	1.71B	1.13B	666M	1.97B	1.59B
Total Revenues (As Reported)	9.13B	8.12B	7.79B	9.38B	8.88B
Effective Tax Rate - (Ratio)	23.32	26.21	23.81	15.84	20.12
Total Current Taxes	252M	147M	93.93M	235M	192M
Total Deferred Taxes	17.17M	-17.97M	-7.44M	-42.81M	-493K
Normalized Net Income	856M	490M	170M	958M	699M
Interest Capitalized	-	-	-	-	-
Interest on Long-Term Debt	10.56K	58.14K	48.38K	30.52K	48.33K
Supplemental Operating Expense Items
Advertising Expense	21.3M	19.59M	21.25M	18.46M	9.45M
Marketing Expenses	937M	744M	896M	965M	773M
Selling and Marketing Expenses	1.13B	891M	1.05B	1.1B	894M
General and Administrative Expenses	417M	422M	436M	578M	515M
Research And Development Expense From Footnotes	807M	809M	860M	749M	580M
Net Rental Expense, Total	19.23M	27.75M	25.72M	24.14M	24.08M
Imputed Operating Lease Interest Expense	6.49M	19.34M	7M	6.51M	5.86M
Imputed Operating Lease Depreciation	12.74M	8.4M	18.72M	17.64M	18.22M
Maintenance & Repair Expenses, Total	10.99M	10.38M	9.38M	8.34M	6.11M
Stock-Based Comp., R&D Exp. (Total)	36.26M	7.28M	26.88M	3.59M	1.87M
Stock-Based Comp., S&M Exp. (Total)	-	-	-	-	311K
Stock-Based Comp., G&A Exp. (Total)	5.98M	26.01M	10.58M	10.1M	9.71M
Total Stock-Based Compensation	42.24M	33.3M	37.46M	13.69M	11.9M

Fiscal Period: December	2021	2022	2023	2024	2025
Assets
Cash And Equivalents	1.77B	1.44B	1.46B	1.97B	3.17B
Short Term Investments	2.9M	-	-	-	-
Trading Asset Securities, Total	454M	447M	328M	295M	250M
Total Cash And Short Term Investments	2.23B	1.89B	1.79B	2.26B	3.42B
Accounts Receivable, Total	1.59B	1.5B	1.42B	1.83B	1.67B
Other Receivables	105M	67.35M	239M	195M	115M
Total Receivables	1.7B	1.57B	1.66B	2.03B	1.79B
Inventory	1.87B	1.99B	2.01B	2.13B	1.85B
Prepaid Expenses	359K	28.66K	-	-	-
Other Current Assets, Total	236M	207M	144M	166M	149M
Total Current Assets	6.03B	5.65B	5.6B	6.58B	7.21B
Gross Property Plant And Equipment	9.02B	9.82B	10.77B	11.46B	11.91B
Accumulated Depreciation	-3.66B	-4.2B	-4.75B	-5.34B	-6.01B
Net Property Plant And Equipment	5.36B	5.62B	6.02B	6.12B	5.9B
Long-term Investments	126M	145M	166M	157M	138M
Goodwill	36.03M	27.91M	18.68M	-	-
Other Intangibles, Total	729M	748M	744M	684M	603M
Deferred Tax Assets Long-Term	78.51M	77.41M	82.12M	125M	125M
Deferred Charges Long-Term	414K	8.85M	6.22M	12.81M	8.77M
Other Long-Term Assets, Total	168M	153M	141M	111M	99.68M
Total Assets	12.53B	12.43B	12.78B	13.8B	14.09B
Liabilities
Accounts Payable, Total	898M	702M	744M	745M	815M
Accrued Expenses, Total	528M	264M	254M	545M	533M
Short-term Borrowings	220M	82.25M	231M	278M	243M
Current Portion of Long-Term Debt	450M	-	370M	306M	273M
Current Portion of Leases	-	-	300K	556K	343K
Current Income Taxes Payable	154M	21.75M	11.88M	171M	78.56M
Unearned Revenue Current, Total	53.81M	61.88M	43.95M	29.31M	32M
Other Current Liabilities	721M	1.33B	823M	495M	465M
Total Current Liabilities	3.02B	2.47B	2.48B	2.57B	2.44B
Long-Term Debt	250M	200M	230M	171M	357M
Long-Term Leases	1.16M	620K	323K	145K	359K
Unearned Revenue Non Current	53.08M	54.11M	84.16M	105M	131M
Deferred Tax Liability Non Current	20.83M	2.47M	-	-	-
Other Non Current Liabilities	-	-	-	82.2M	73.7M
Total Liabilities	3.35B	2.72B	2.79B	2.93B	3B
Common Stock, Total	965M	965M	965M	962M	962M
Additional Paid In Capital	1.69B	1.94B	2.01B	1.99B	1.87B
Retained Earnings	6.2B	6.42B	6.68B	7.7B	8.22B
Treasury Stock	-59.98M	-57.69M	-27.63M	-	-125M
Comprehensive Income and Other	-13.99M	-5.27M	5.77M	-1.36M	15.27M
Total Common Equity	8.78B	9.26B	9.63B	10.65B	10.94B
Minority Interest	403M	450M	356M	220M	146M
Total Equity	9.18B	9.71B	9.99B	10.87B	11.09B
Total Liabilities And Equity	12.53B	12.43B	12.78B	13.8B	14.09B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	958M	958M	926M	962M	948M
ECS Total Common Shares Outstanding	958M	958M	926M	962M	948M
Book Value / Share	9.16	9.66	10.4	11.07	11.54
Tangible Book Value	8.01B	8.48B	8.87B	9.96B	10.34B
Tangible Book Value Per Share	8.36	8.85	9.58	10.36	10.91
Total Debt	922M	283M	833M	756M	874M
Net Debt	-1.3B	-1.6B	-956M	-1.5B	-2.54B
Debt Equivalent Oper. Leases	154M	222M	206M	193M	193M
Minority Interest, Total (Incl. Fin. Div)	403M	450M	356M	220M	146M
Equity Method Investments, Total	45.45M	67.88M	88.23M	86.06M	68.62M
Account Code - Inventory Valuation	6	6	6	6	6
Inventories - Raw Materials, Total	226M	231M	200M	197M	193M
Inventories - Work In Process, Total	630M	634M	760M	675M	735M
Inventories - Finished Goods, Total	1.18B	1.26B	1.2B	1.46B	1.14B
Buildings, Total	2.51B	2.81B	2.92B	3.03B	3.3B
Machinery, Total	5.37B	6.16B	6.9B	7.42B	7.95B
Full Time Employees	5.9K	6.21K	6.23K	5.82K	5.42K
Accumulated Allowance for Doubtful Accounts (Supple)	49.59M	43.8M	43.95M	56.43M	52.71M

Fiscal Period: December	2021	2022	2023	2024	2025
Net Income	1.05B	540M	430M	1.16B	873M
Depreciation & Amortization - CF	523M	602M	644M	641M	695M
Amortization of Goodwill and Intangible Assets - (CF)	9.14M	14.47M	15.33M	15.96M	16.06M
Depreciation & Amortization, Total	533M	616M	659M	657M	711M
Amortization of Deferred Charges, Total - (CF)	55.14M	69.23M	68.24M	69.86M	87.31M
(Gain) Loss From Sale Of Asset	7.95M	-3.31M	-330M	-3.09M	81.15K
(Gain) Loss on Sale of Investments - (CF)	-104M	56.51M	28.59M	29.6M	-7.49M
Asset Writedown & Restructuring Costs	56.83M	12.8M	15.81M	96.4M	32.1M
Provision and Write-off of Bad Debts	10.63M	-2.94M	149K	12.55M	-3.67M
Other Operating Activities, Total	58.32M	-73.46M	-76.42M	31.24M	11.14M
Change In Accounts Receivable	-402M	-162M	-29.42M	-759M	144M
Change In Inventories	-761M	-331M	-264M	-347M	32.7M
Change In Accounts Payable	578M	-218M	102M	305M	-6.17M
Change In Deferred Taxes	17.17M	-16.53M	-6.94M	-42.81M	-493K
Change in Other Net Operating Assets	42.24M	33.35M	37.47M	13.69M	11.9M
Cash from Operations	1.14B	521M	634M	1.22B	1.89B
Capital Expenditure	-940M	-976M	-797M	-689M	-446M
Sale of Property, Plant, and Equipment	6.97M	7.2M	174M	200M	1.87M
Cash Acquisitions	-141M	-	-	-	-
Divestitures	-	9.12M	-	-	-
Investment in Marketable and Equity Securities, Total	39.13M	-40.46M	102M	14.08M	71.95M
Net (Increase) Decrease in Loans Originated / Sold - Investing	48.56M	27.22M	1M	-	-
Other Investing Activities, Total	1.98M	1.75M	777K	1.07M	713K
Cash from Investing	-984M	-971M	-519M	-473M	-372M
Long-Term Debt Issued, Total	580M	650M	600M	520M	695M
Total Debt Issued	580M	650M	600M	520M	695M
Long-Term Debt Repaid, Total	-700M	-726M	-600M	-574M	-578M
Total Debt Repaid	-700M	-726M	-600M	-574M	-578M
Issuance of Common Stock	-	-	-	-	-
Repurchase of Common Stock	-	-	-1.29M	-29M	-200M
Common Dividends Paid	-260M	-351M	-192M	-170M	-377M
Common & Preferred Stock Dividends Paid	-260M	-351M	-192M	-170M	-377M
Other Financing Activities, Total	450M	471M	52.12M	-2.38M	56.52M
Cash from Financing	69.75M	43.91M	-141M	-255M	-403M
Foreign Exchange Rate Adjustments	-79.84M	76.01M	47.64M	11.27M	90.29M
Net Change in Cash	143M	-331M	21.93M	506M	1.2B
Supplemental Items
Cash Interest Paid	-	400K	400K	400K	400K
Cash Income Tax Paid (Refund)	384M	345M	163M	353M	398M
Levered Free Cash Flow	631M	-349M	-60.17M	415M	1.35B
Unlevered Free Cash Flow	656M	-328M	-42.46M	431M	1.37B
Change In Net Working Capital	-240M	377M	-674K	426M	-469M
Net Debt Issued / Repaid	-120M	-76.21M	-342K	-53.63M	117M

Fiscal Period: December	2021	2022	2023	2024	2025
Profitability
Return on Assets	6.3	2.45	-0.09	6.07	3.85
Return on Total Capital	7.61	3.12	-0.11	7.2	4.55
Return On Equity %	10.28	3.84	2.81	9.78	6.92
Return on Common Equity	12.71	5.98	4.55	11.45	8.09
Margin Analysis
Gross Profit Margin %	39.43	33	30.82	40.37	32.61
SG&A Margin	16.94	16.17	19.01	17.9	15.87
EBITDA Margin %	18.55	13.62	8.22	20.76	17.67
EBITA Margin %	12.82	6.21	-0.04	13.94	9.86
EBIT Margin %	12.72	6.03	-0.23	13.77	9.68
Income From Continuing Operations Margin %	9.69	4.47	3.55	10.88	8.56
Net Income Margin %	11.45	6.65	5.51	12.38	9.83
Net Avail. For Common Margin %	11.45	6.65	5.51	12.38	9.83
Normalized Net Income Margin	9.38	6.03	2.18	10.22	7.87
Levered Free Cash Flow Margin	6.91	-4.3	-0.77	4.42	15.25
Unlevered Free Cash Flow Margin	7.18	-4.04	-0.54	4.6	15.43
Asset Turnover
Asset Turnover	0.79	0.65	0.62	0.71	0.64
Fixed Assets Turnover	1.85	1.48	1.34	1.54	1.48
Receivables Turnover (Average Receivables)	6.07	5.22	5.32	5.75	5.04
Inventory Turnover (Average Inventory)	3.3	2.81	2.69	2.7	3
Short Term Liquidity
Current Ratio	2	2.29	2.26	2.56	2.96
Quick Ratio	1.3	1.4	1.39	1.67	2.13
Operating Cash Flow to Current Liabilities	0.38	0.21	0.26	0.48	0.77
Days Sales Outstanding (Average Receivables)	60.17	69.96	68.65	63.7	72.4
Days Outstanding Inventory (Average Inventory)	110.67	129.81	135.56	135.62	121.59
Average Days Payable Outstanding	43.22	52.54	48.81	47.69	49.87
Cash Conversion Cycle (Average Days)	127.63	147.24	155.4	151.63	144.13
Long Term Solvency
Total Debt/Equity	10.04	2.92	8.34	6.96	7.89
Total Debt / Total Capital	9.13	2.83	7.7	6.51	7.31
LT Debt/Equity	2.74	2.07	2.31	1.58	3.22
Long-Term Debt / Total Capital	2.49	2.01	2.13	1.47	2.99
Total Liabilities / Total Assets	26.73	21.9	21.86	21.22	21.3
EBIT / Interest Expense	29.38	14.79	-0.64	48.94	34.63
EBITDA / Interest Expense	42.85	33.4	22.63	73.84	63.27
(EBITDA - Capex) / Interest Expense	19.08	3.92	-5.49	47.71	45.28
Total Debt / EBITDA	0.54	0.26	1.3	0.39	0.56
Net Debt / EBITDA	-0.77	-1.45	-1.49	-0.77	-1.62
Total Debt / (EBITDA - Capex)	1.22	2.18	-5.35	0.6	0.78
Net Debt / (EBITDA - Capex)	-1.73	-12.34	6.14	-1.2	-2.26
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	24.6	-11.1	-3.96	20.29	-5.28
Gross Profit, 1 Yr. Growth %	23.39	-25.59	-10.31	57.56	-23.47
EBITDA, 1 Yr. Growth %	32.17	-36.75	-45.29	165.81	-22.02
EBITA, 1 Yr. Growth %	48.22	-58.82	-100.49	1.37K	-36.22
EBIT, 1 Yr. Growth %	49.42	-57.79	-103.71	16.08K	-33.4
Earnings From Cont. Operations, 1 Yr. Growth %	34.1	-59.01	-23.67	268.6	-25.49
Net Income, 1 Yr. Growth %	45.71	-48.38	-20.37	170.11	-24.74
Normalized Net Income, 1 Yr. Growth %	53.42	-42.75	-65.22	413.71	-27.05
Diluted EPS Before Extra, 1 Yr. Growth %	45.33	-48.62	-20.13	168.18	-24.79
Accounts Receivable, 1 Yr. Growth %	13.68	-5.87	-5.41	28.96	-8.53
Inventory, 1 Yr. Growth %	26.58	6.47	0.81	6.06	-13.03
Net Property, Plant and Equip., 1 Yr. Growth %	18.75	4.82	7.14	1.69	-3.54
Total Assets, 1 Yr. Growth %	19.35	-0.8	2.79	7.95	2.14
Tangible Book Value, 1 Yr. Growth %	10.32	5.86	4.52	12.36	3.78
Common Equity, 1 Yr. Growth %	14.39	5.48	4	10.56	2.77
Cash From Operations, 1 Yr. Growth %	-9.55	-54.2	21.84	92.85	54.15
Capital Expenditures, 1 Yr. Growth %	75.51	3.87	-18.35	-13.52	-35.21
Levered Free Cash Flow, 1 Yr. Growth %	2.85	-132.41	-93.31	-2.11K	226.53
Unlevered Free Cash Flow, 1 Yr. Growth %	2.06	-129.8	-95.17	-14.78K	217.65
Dividend Per Share, 1 Yr. Growth %	43.48	-48.48	-11.76	146.67	-24.32
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	13.84	5.25	-7.6	7.48	6.74
Gross Profit, 2 Yr. CAGR %	13.94	-4.18	-18.31	18.87	9.81
EBITDA, 2 Yr. CAGR %	49.64	-7.13	-39.45	28.94	46.41
EBITA, 2 Yr. CAGR %	104.21	-20.1	-95.2	51.44	213.82
EBIT, 2 Yr. CAGR %	108.01	-20.63	-87.49	62.33	937.91
Earnings From Cont. Operations, 2 Yr. CAGR %	74.06	-25.86	-44.06	67.74	65.73
Net Income, 2 Yr. CAGR %	74.63	-13.28	-35.89	46.66	42.58
Normalized Net Income, 2 Yr. CAGR %	89.94	-6.32	-55.4	39.93	93.59
Diluted EPS Before Extra, 2 Yr. CAGR %	74.01	-13.59	-35.94	46.8	42.2
Accounts Receivable, 2 Yr. CAGR %	-0.36	3.44	-5.64	10.45	8.61
Inventory, 2 Yr. CAGR %	14.26	16.09	3.6	3.4	-3.96
Net Property, Plant and Equip., 2 Yr. CAGR %	9.63	11.57	5.98	4.38	-0.96
Total Assets, 2 Yr. CAGR %	9.97	8.81	0.98	5.34	5
Tangible Book Value, 2 Yr. CAGR %	3.69	8.07	5.19	8.37	7.98
Common Equity, 2 Yr. CAGR %	5.68	9.84	4.74	7.23	6.6
Cash From Operations, 2 Yr. CAGR %	59.42	-35.64	-25.3	53.29	72.42
Capital Expenditures, 2 Yr. CAGR %	27.98	35.02	-7.91	-15.97	-25.15
Levered Free Cash Flow, 2 Yr. CAGR %	64.38	-24.63	-76.35	-32.09	709.98
Unlevered Free Cash Flow, 2 Yr. CAGR %	73.65	-28.56	-80.36	-29.95	2.06K
Dividend Per Share, 2 Yr. CAGR %	-42.55	-14.03	-32.58	47.53	36.63
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	10	4.83	2.08	0.89	3.05
Gross Profit, 3 Yr. CAGR %	9.12	-1.15	-6.27	1.69	2.64
EBITDA, 3 Yr. CAGR %	22.77	13.48	-20.64	3.66	10.27
EBITA, 3 Yr. CAGR %	32.96	21.55	-84.72	2.19	15.4
EBIT, 3 Yr. CAGR %	33.68	22.19	-71.42	3.61	20.62
Earnings From Cont. Operations, 3 Yr. CAGR %	39.31	7.49	-25.13	4.87	27.99
Net Income, 3 Yr. CAGR %	42.07	16.33	-15.71	3.55	17.41
Normalized Net Income, 3 Yr. CAGR %	35.39	27.31	-32.69	3.85	12.62
Diluted EPS Before Extra, 3 Yr. CAGR %	42.08	15.87	-15.83	3.45	17.57
Accounts Receivable, 3 Yr. CAGR %	1.16	-2.23	0.4	4.72	3.72
Inventory, 3 Yr. CAGR %	16.26	11.6	10.76	4.41	-2.39
Net Property, Plant and Equip., 3 Yr. CAGR %	6.52	8	10.07	4.53	1.67
Total Assets, 3 Yr. CAGR %	7.64	6.26	6.77	3.25	4.26
Tangible Book Value, 3 Yr. CAGR %	3.47	4.41	6.87	7.53	6.82
Common Equity, 3 Yr. CAGR %	4.71	5.61	7.86	6.65	5.73
Cash From Operations, 3 Yr. CAGR %	25.15	5.19	-20.38	2.48	53.58
Capital Expenditures, 3 Yr. CAGR %	28.84	19.38	14.18	-9.82	-22.95
Levered Free Cash Flow, 3 Yr. CAGR %	537.98	14.28	-53.89	-27.21	14.62
Unlevered Free Cash Flow, 3 Yr. CAGR %	294.13	14.67	-59.57	-26.82	15.95
Dividend Per Share, 3 Yr. CAGR %	30.06	-44.6	-13.28	3.89	18.1
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	11.58	7.35	2.59	5.88	3.92
Gross Profit, 5 Yr. CAGR %	20.78	10.81	-2.81	6.42	-0.14
EBITDA, 5 Yr. CAGR %	12.76	11.23	-6.89	20.81	4.14
EBITA, 5 Yr. CAGR %	14.24	12.14	-64.47	36.01	2.08
EBIT, 5 Yr. CAGR %	14.5	12.42	-48.19	36.89	2.03
Earnings From Cont. Operations, 5 Yr. CAGR %	14.76	8.65	-3.29	28.43	2.88
Net Income, 5 Yr. CAGR %	18.36	16.34	3.34	27.62	4.01
Normalized Net Income, 5 Yr. CAGR %	17.23	19.99	-13.18	32.2	4.61
Diluted EPS Before Extra, 5 Yr. CAGR %	17.82	15.71	3.31	27.37	3.94
Accounts Receivable, 5 Yr. CAGR %	6.72	-0.26	-1.62	2.66	3.61
Inventory, 5 Yr. CAGR %	12.76	15.49	11.02	8.25	4.62
Net Property, Plant and Equip., 5 Yr. CAGR %	5.22	5.05	6.3	6.54	5.52
Total Assets, 5 Yr. CAGR %	7.29	4.89	4.93	5.89	6.06
Tangible Book Value, 5 Yr. CAGR %	4.15	4.31	4.16	5.98	7.31
Common Equity, 5 Yr. CAGR %	4.7	4.9	4.72	6.26	7.35
Cash From Operations, 5 Yr. CAGR %	27.59	0.67	1.81	22.29	8.46
Capital Expenditures, 5 Yr. CAGR %	19.74	11.36	12.65	3.74	-3.57
Levered Free Cash Flow, 5 Yr. CAGR %	29.89	113.2	89.99	12.17	17.16
Unlevered Free Cash Flow, 5 Yr. CAGR %	29.25	149.11	31.71	14.67	16.35
Dividend Per Share, 5 Yr. CAGR %	17.88	16.27	0	-18.03	4.01